CVS is overhauling how it reimburses pharmacies for prescription drugs, a move that could change how much consumers pay for their prescriptions. The company said in a statement Tuesday that its new pharmacy reimbursement model will bring more transparency and simplicity to its drug pricing. system.Currently, the prices consumers pay for drugs and the payments pharmacies receive are largely determined by intermediaries known as pharmacy benefit managers who negotiate discounts from drug manufacturers to insurers. These complex reimbursement formulas are not based directly on what the pharmacy spent to purchase specific drugs. The new approach, dubbed CVS CostVantage, will use a simple formula that includes drug price, a fixed markup and a fee to determine drug price and reimbursement. with pharmacy benefit managers. It is expected to launch for commercial payers in 2025. The Wall Street Journal first reported the news. The measure may change the cost of prescription drugs for some patients, but it won’t necessarily lower the cost of all drugs. CVS executives said some drugs could be cheaper, while others could be more expensive. More prescription drug costs should come down rather than up for consumers, employers and health insurers, they said. We are leading the way with an approach that is changing the way we compensate our retail pharmacy by implementing a more transparent and sustainable model that fairly aligns pharmacy reimbursement to quality services. We provide, Prem Shah, co-president of CVS Pharmacy and chief pharmacy officer of CVS Health, said in a statement. It provides a first step towards greater price clarity for consumers and our payer customers. The announcement is the latest in a series of changes that will disrupt the prescription drug pricing model. The high cost of drugs is one of the biggest health care headaches for Americans, and the lack of transparency in how prices are set has caught the attention of many players, including Congress, which is considering several bills to shed more light on the process. CVS Caremarks business took a significant hit over the summer when a major health insurer in California. , Blue Shield of California, announced that it will no longer use the company as its drug benefit manager and will instead partner with several companies, including Amazon Pharmacy and Mark Cuban Cost Plus Drug Company. Tuesday. Blue Shield said earlier this year that the Cuban pricing model would be simpler, more transparent and more affordable. The move could shake up the prescription drug pricing system beyond Blue Shields’ 4.8 million members.
CVS is overhauling how it reimburses pharmacies for prescription drugs, a move that could change how much consumers pay for their prescriptions.
The company announced Tuesday that its new pharmacy reimbursement model will bring more transparency and simplicity to its drug pricing system.
Currently, the prices consumers pay for drugs and the payments pharmacies receive are largely determined by middlemen known as pharmacy benefit managers who negotiate discounts from drug manufacturers to insurers. These complex reimbursement formulas are based directly on what the pharmacy spent on purchasing the particular drug.
The new approach, dubbed CVS CostVantage, will use a simple formula that includes the price of the drug, a fixed markup, and a fee to determine drug prices and reimburse drug benefit managers. It is expected to launch for commercial payers in 2025. The Wall Street Journal first reported the news.
This measure may change the price of prescription drugs for some patients, but it will not necessarily lower the price of all drugs. CVS executives said some drugs could be cheaper, while others could be more expensive. Rising prescription drug costs should come down for consumers, employers and health insurers, they said.
“We are leading the way with an approach that changes the way we compensate our retail pharmacy by implementing a more transparent and sustainable model that fairly aligns drug reimbursement with the quality services we provide,” said Prem Shah, CVS Pharmacy co-president and chief pharmacy officer. CVS Health, in a statement. It provides our [pharmacy benefit managers] And paying clients is a fundamental step towards making prices more clear for consumers.
The announcement is the latest in a series of changes that will shake up the prescription drug pricing model.
The high cost of drugs is one of the biggest health care headaches for Americans, and the lack of transparency in how prices are set has caught the attention of many players, including Congress, which is considering several bills to shed more light on the process.
CVS Caremarks’ business took a significant hit over the summer when major California health insurer Blue Shield of California announced it would no longer use the company as its drug benefit manager and would instead partner with several companies, including Amazon Pharmacy and Mark Cuban Cost. Plus Pharmaceuticals Co.
The Cuban company uses a similar pricing model to CVS, which was announced Tuesday. Blue Shield said earlier this year that the Cuban pricing model would be simpler, more transparent and more affordable. The move could shake up the prescription drug pricing system beyond Blue Shields’ 4.8 million members.
#CVS #change #prescription #drug #prices
Image Source : www.wmur.com